SSX2 and synovial sarcoma: In synovial sarcoma, H2AK119ub1-modified nucleosomes provide an interface for SS18-SSX, resulting in the rewiring of an altered BAF complex to Polycomb targets, leading to their aberrant activation and resulting in the oncogenic gene expression signatures characteristic of synovial sarcoma6,7,16,17.